Skip to main content
. 2022 Nov 12;12:05046. doi: 10.7189/jogh.12.05046

Table 2.

Perceptions and preventive practices regarding COVID-19 among health care providers in a phone-based survey in five sub-Saharan African countries, 2021*

Burkina Faso Ethiopia Nigeria Tanzania Ghana

Ouagadougou
Addis Ababa
Ibadan and Lagos
Dar es Salaam
Kintampo
Total
Number of health care providers
300
277
312
310
300
1499
Concerned about the spread of COVID-19
276 (92.0)
268 (96.7)
303 (97.1)
257 (83.0)
299 (99.7)
1403(93.6)
Perceived level of risk of COVID-19 exposure






No risk
4 (1.3)
1 (0.4)
2 (0.6)
12 (3.9)
4 (1.3)
23 (1.5)
Low risk
122 (40.7)
36 (13.0)
29 (9.3)
29 (9.3)
28 (9.3)
244 (16.3)
High risk
140 (46.7)
136 (49.1)
164 (52.6)
188 (60.7)
176(58.7)
804 (53.6)
Very high risk
34 (11.3)
104 (37.5)
117 (37.5)
81 (26.1)
92 (30.7)
428 (28.6)
Preventive measures implemented in the workplace






Wearing masks
295 (98.3)
275 (99.3)
311 (99.7)
279 (90.0)
298 (99.3)
1458(97.3)
Using personal protective equipment
274 (91.3)
231(83.4)
231 (74.0)
192 (61.9)
165 (55.0)
1093 (72.9)
Hand washing
296 (98.7)
258 (93.1)
309 (99.0)
299 (96.4)
300 (100)
1462 (97.5)
Keeping sufficient distance between patients
131 (43.7)
183 (66.1)
280 (89.7)
203 (65.5)
243 (81.0)
1040 (69.4)
Presence of sanitizers/ hand washing station
268 (89.3)
208 (75.1)
301 (96.5)
303 (97.7)
293 (97.7)
1373 (91.6)
Regular cleaning/decontamination
268 (89.3)
220 (79.4)
286 (91.7)
241 (77.7)
292 (97.3)
1307 (87.2)
Temperature checks
257 (85.6)
154 (55.6)
279 (89.4)
208 (67.1)
288 (96.0)
1186 (79.1)
Workplace formulated COVID-19 guidelines/policies
180 (60.0)
208 (75.1)
297 (95.2)
208 (67.1)
269 (89.7)
1162 (77.5)
COVID-19 formal training/orientation in the workplace in the past 6 months






Natural course
35 (11.7)
90 (32.5)
195 (62.5)
78 (25.2)
163 (54.3)
561(37.4)
Management and treatment
31 (10.4)
89 (32.1)
183 (58.7)
72 (23.2)
133 (44.3)
508 (33.9)
How vaccines work
20 (6.7)
81 (29.2)
160 (51.3)
74 (23.9)
105 (35.0)
440 (29.3)
Managing vaccination programs
36 (12.0)
77 (27.8)
112 (35.9)
66 (21.3)
52 (17.3)
343 (22.9)
Type of COVID-19 treatment available in facility






Corticosteroids
31 (10.3)
129 (46.6)
54 (17.3)
90 (29.0)
13 (4.3)
317 (21.1)
Remdesivir
3 (1.0)
73 (26.4)
31 (9.9)
11 (3.5)
0 (0)
118 (7.9)
Antibiotics
131 (43.7)
174 (62.8)
136 (43.6)
176 (56.8)
91 (30.3)
708 (47.2)
Ivermectin
5 (1.68)
47 (17.0)
91 (29.2)
13 (4.2)
1 (0.3)
157 (10.5)
Chloroquine
116 (38.7)
28 (10.1)
18 (5.8)-
6 (1.9)
18 (6.0)
186 (12.4)
Multivitamin
42 (14.0)
82 (29.6)
141 (45.2)
139 (44.5)
96 (32.0)
500 (33.4)
COVID-19 testing available at the workplace
175 (58.3)
240 (86.6)
205 (65.7)
111 (35.8)
112 (37.3)
843 (56.2)
If yes, free testing available
154 (88.0)
209 (87.1)
154 (75.1)
40 (36.0)
85 (75.9)
642 (76.2)
If yes, type of COVID-19 test available†






PCR
108 (61.7)
118 (50.2)
124 (60.5)
24 (21.4)
46 (41.1)
420 (50.1)
Antigen
90 (51.4)
134 (56.3)
85 (41.5)
55 (49.1)
17 (15.2)
381 (45.2)
Ever been tested for COVID-19
143 (47.7)
216 (78.0)
169 (54.2)
42 (13.5)
128 (42.8)
698 (46.6)
Tested positive for COVID-19
14 (9.8)
68 (31.5)
39 (23.1)
13 (30.9)
26 (20.3)
160 (22.9)
Has treated COVID-19 patients 101 (33.7) 232 (83.7) 146 (47.1) 144 (46.7) 82 (27.3) 705 (47.0)

N – number of observations

*Number of observations (percentage).

†Counts and percentages do not add up to the total due to multi-response.